← Tra cứu cổ phiếu

iShareInvest Research

HOSE · Quý 2/2026

JVC

Đầu tư Y tế - Dược phẩm Việt Nam

Analysis of business results & financial statements · Quý 2/2026

▼ Under pressure

Trailing net profit reached 50.8bn, fell 13.1bn compared with the same period last year. Key positives came from higher gross profit, lower tax, lower administrative expenses, and higher financial income. Offsetting pressure came mainly from higher finance costs, higher selling expenses, and weaker other profit. Detailed impact is shown below:

See what is changing ↓
P/E
6.63x
P/B
0.51x
EPS
444
BVPS
5,814
ROE
8.3%
ROA
5.3%
Market price
2,940
19 Oct 2026

What Is Changing

On a TTM 2026Q2 basis, JVC is holding revenue at an acceptable level, but margins are eroding visibly. What is still missing is better cost control to prevent margin pressure from spreading to the overall profit result.

Profit bridge

Vs last year · TTM

  1. Gross profit
  2. Tax
  3. Administrative expenses
  4. Financial income
  5. Finance costs
  6. Selling expenses
  7. Other profit
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 2/2026

MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue142.4159.1284.9161.2136.3181.2188.7148.0
LNST16.710.89.912.63.124.528.08.4
Net margin11.72%6.79%3.46%7.83%2.27%13.50%14.82%5.71%

Revenue

142bn

Net income

17bn

Net margin

11.72%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins narrowed but earnings quality remains clean — pressure is mainly operational.

Revenue Growth

▲

Is growth real and durable?

Trailing-12-month revenue grew 14.3% year on year — but the quarterly pace is slowing (+9% → +4%).

3 of the last 4 quarters grew year on year.

Revenue TTM
748bn
+14.3%
Latest quarter YoY
+4%
slowing

What is driving the margin?

▼▼

Net margin fell to 6.68%, losing 3.1pp. The main pressure is Gross margin fell 2.3pp, outweighing the improvement in SG&A / Revenue fell 1.3pp (with lingering pressure from Net financial result / Revenue fell 1.6pp and Other profit / Revenue fell 0.8pp).

The pressure comes from non-core items while core operations hold their rhythm — margin has a basis to recover once this factor passes.

Net Margin
6.68%
−3.1pp
Gross Margin
22.44%
−2.3pp
SG&A / Revenue
13.83%
−1.3pp

TTM YoY · 2025Q2 -> 2026Q2

Cash Flow

●

Is profit converting into cash?

Operating cash flow reached -88.5bn against investing cash flow of -101.1bn (annual cash-flow figures for 2025).

Post-investment cash flow was negative +189.6bn. Financing cash flow was positive +199.3bn.

CFO / net income was 5,12 lần.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Earnings Quality

●

How much income is non-core?

Non-core income makes up 14.4% of pre-tax profit — worth monitoring.

Within that, net financial result at −15.0%, other profit at +14.4% of PBT.

Non-core / PBT
14.4%
moderate
Net financial / PBT
−15.0%
Other profit / PBT
14.4%
02

Is capital being used efficiently?

Capital efficiency is declining — check whether the drag is from margins or turnover.

Is capital being deployed efficiently?

▼

ROIC fell to 5.68%, losing 1.9pp. That translates to 5.68 in after-tax operating profit for every 100 units of operating capital. The main pressure came from NOPAT margin narrowed 2.1pp, outweighing the movement in capital turnover; while invested capital rose by 75bn.

Pressure came from the margin side — core operations are weakening, not just a temporary asset-management issue.

Working Capital Efficiency

▲▲

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 70.9 days versus the same period last year. The main moves came from DIO rose 5.8 days, DSO fell 72.0 days, and DPO rose 4.7 days.

Improvement comes mainly from faster receivables collection — reflects the quality of receivables management.

Cash conversion cycle remains stretched

CCC stands at 173.9 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Inventory turnover is slowing

DIO increased by +5.8 days, suggesting more capital is being tied up in inventories.

DuPont

What drives ROE?

Net margin 6.7% -3.1pp
Asset turnover 0.78x -0.05x
Financial leverage 1.57x +0.11x
ROE 8.2% -3.6pp

ROE fell from 11.8% to 8.2% — net margin weakened the most, though leverage still provided support.

03

Is financial risk significant?

Check leverage, liquidity, and cash-flow conversion.

Leverage & Liquidity

●

Leverage is balanced for now, with net debt / equity at 0.14x and interest coverage at 2.22x.

At present, short-term debt accounts for 89.2% of total debt, cash equals 60.1% of debt, and total debt stands at 225.2bn.

Net Debt / Equity
0.14x
−0.21x
Interest Coverage
2.22x
−4.13x
Cash / Debt
60.1%
+50.7pp
Short-term Debt / Total Debt
89.2%
+5.2pp

TTM YoY · 2025Q2 -> 2026Q2

Short-term refinancing pressure is meaningful

Short-term debt accounts for 89.2% of total debt, raising near-term refinancing needs.

Balance Sheet

▲

The balance sheet shows capital-allocation efficiency slipping. Capital structure is conservative with low leverage — liabilities at 0.71x equity, net debt at 0.14x equity.

Inventory ended the period at 121.4bn, roughly 11.3% of total assets.

Over the last 12 months, working capital released 192.9bn of cash, mainly thanks to lower receivables and lower inventories.

Research synthesis

What this reporting period is showing

The business is under real pressure, but the current picture has not turned broadly adverse. A notable area has clearly weakened, making the near-term outlook hard to call bright; even so, other parts of the business are still holding up, with margins remain under pressure remaining the main constraint, with net margin down 3.1 pp. The next watchpoint is cash generation still needs confirmation. The main offsetting support comes from earnings conversion is confirmed, with CFO/NI at 5.12x.

  • Improvement: earnings conversion looks more confirmed, with CFO / net income at 5.12x.
  • Watchpoint: Cash generation still needs confirmation.
  • Key risk: profitability remains under pressure, with trailing-12M net margin at 6.68% after a 3.1pp decline versus the same period last year.

Questions for the next period

  1. Whether revenue sustains its +14,3% YoY pace or begins to slow.

  2. Whether margins hold around the current 6.68% level or narrow again.

  3. Whether operating cash flow holds its -88.5bn (cumulative for 2025) level in upcoming periods or weakens.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio